WHO ICTRP trial
A Study of RBx 10017609 in Elderly Male and Female Subjects
CTRI/2009/091/000749 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/000749 |
|---|---|
| Public title | A Study of RBx 10017609 in Elderly Male and Female Subjects |
| Scientific title | A Single-Blind, Randomized, Placebo Controlled, Single Dose Safety, Tolerability and Pharmacokinetic Study of RBx 10017609 in Elderly Male and Female Subjects |
| Primary sponsor | Ranbaxy Laboratories Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Phase | Phase 1 |
| Countries | India |
| Interventions | Intervention1: RBx 10017609: 400 mg oral single dose Control Intervention1: placebo: 400 mg oral single dose |
| Registration date | Mar 19, 2010 |
| Target size | 24 |
| Secondary IDs | 101_17609_09 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: